Clinical Trial Update: A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants. [Phase 1]

View source ↗

Summary

Phase 1 trial comparing CKD-706 with US- and EU-Dupixent (dupilumab) in healthy adult participants with atopic dermatitis, assessing pharmacokinetics, pharmacod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• CKD-706
• DUPIXENT (DUPILUMAB)

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Atopic Dermatitis | Phase 1 | Status: RECRUITING